Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Quigley files IND for clinical trials of QR-333 in diabetic peripheral neuropathy

March 10, 2006

Novo Nordisk reinitiates phase III program for AERx iDMS

March 10, 2006

New phase I/II trial evaluates BDM-E for diabetic macula edema

March 9, 2006

Novel antidiabetic agents disclosed in recent patents

March 8, 2006

Phase III efficacy trials begin for Technosphere Insulin

March 8, 2006

GSK discloses preclinical data on relacatib, a novel cathepsin K inhibitor

March 7, 2006

Design announced for phase III iron therapy program of ferumoxytol

March 7, 2006

Recent patents report novel agents for metabolic disorders

March 6, 2006

Nastech reacquires rights to PYY3-36 nasal spray from Merck

March 6, 2006

sNDA seeks approval of Byetta for use with TZDs

March 3, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
NTX-819, a novel mGlu7 NAM for psychiatric disorders
BioWorld Science
Increasing evidence supports metabotropic glutamate mGlu7 receptor as a promising target in psychiatric disorders. Neurosterix Pharma Sarl has presented data on...